Office of Professional Education

Bronchiectasis Update: Evaluation, Clinical Course, Inflammation and Treatment

 Join Us for a Free CME Lunch Satellite Symposium


Sunday, October 16, 2022
11:30 a.m. to 12 p.m. (CT): Registration and Lunch
12 to 1 p.m. (CT): Educational Program

Omni Nashville Hotel
Legends Ballroom EFG
250 Rep. John Lewis Way South, Nashville, TN 37203

RSVP Now

 

Non-cystic fibrosis bronchiectasis (NCFBE) is a progressive pulmonary condition that leads to bronchial wall damage causing permanent airway dilation, which is primarily due to neutrophil-driven inflammation stemming from chronic or recurrent infection. In patients with bronchiectasis, symptoms such as persistent cough, dyspnea, excessive sputum production, and recurrent pulmonary infections can worsen the disease and lead to impaired quality of life.

This CME satellite symposium, presented by National Jewish Health and the Respiratory Institutes, will focus on assessment of NCFBE and approaches to reduce delay in diagnosis. Attendees will become more adept at assessing patients’ natural history, clinical course, and disease progression and gain a deeper understanding of the role of neutrophilic inflammation and neutrophil serine protease inflammation (NSP) in NCFBE. Lastly, this session will explore current and emerging therapies to optimize clinical outcomes in patients with NCFBE.

Target Audience:

Pulmonologists who treat patients with bronchiectasis.

Program Faculty:

Charles L. Daley, MD Charles L. Daley, MD
Chief, Division of Mycobacterial & Respiratory Infections
Professor
Department of Medicine
National Jewish Health
Denver, CO
   
Jeffrey B. Hoag, MD, MS Jeffrey B. Hoag, MD
Associate Professor of Medicine
Section Chief, Jefferson Northeast
Division of Pulmonary, Allergy and Critical Care Medicine
The Jane and Leonard Korman Respiratory Institute –
Jefferson Health and National Jewish Health
Sidney Kimmel Medical College, Thomas Jefferson University
Philadelphia, PA
   
Steven E. Lommatzsch, MD Steven E. Lommatzsch, MD
Associate Professor of Medicine
Medical Executive Committee President
Director of the Non-CF Bronchiectasis Program
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
National Jewish Health
Denver, CO
   
Sarah Taimur, MD Sarah Taimur, MD
Associate Professor of Medicine
Division of Infectious Diseases
The Mount Sinai – National Jewish Health Respiratory Institute
Icahn School of Medicine at Mount Sinai
New York, NY
 

Learning Objectives:

Upon completion of this activity, participants should be able to:
  • Review bronchiectasis burden, etiologies, and best practice evaluation strategies.
  • Describe the clinical course and progression of bronchiectasis.
  • Describe the role of neutrophilic inflammation in patients with bronchiectasis.
  • Identify current and emerging treatments for patients with bronchiectasis.
 

Contact:

For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email ProEd@njhealth.org.

Accreditation and Designation Statements:

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

National Jewish Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Support:

Supported by an Educational Grant from Insmed. 

Registration Information:

If interested in attending, please RSVP below. Advanced registration is not required for this complimentary CME symposium, however, your RSVP helps us plan for the best experience possible. Please arrive early, as seating may be limited.

*
*
*
*

Respiratory Institute
Collaborative program developed by National Jewish Health
and presented with:
The Mount Sinai – National Jewish Health Respiratory Institute
and the Jane and Leonard Korman Respiratory Institute – Jefferson
Health and National Jewish Health.
 
This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.